Skip to content
Pulse Royal Market

Social Media Influencers Driving Parallel Trade for Unlicensed Slimming Medication

A shadow economy for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.

Experimental Drug Acquiring Popularity Via Social Media

The experimental drug, which remains in research studies, is being promoted by online personalities for its supposed fat-burning properties. Followers are encouraged to message these profiles privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison images, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the sale of what is still an unlicensed drug in the UK is a cause for concern and could result in users administering substances of unknown origin.

Some experts stated the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Selling retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, advertising, and customer regulations, risking penalties, legal action or prison.

Platform Response and Material Removal

According to TikTok, the platform has taken down violative material and prohibited related keywords and search suggestions. The company said it was dedicated to maintaining the service secure and allocating resources in strengthening enforcement strategies.

Digital Marketplace Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or administering at residence.

After minutes of joining one community, a seller posted contact information, where the majority of purchases occur. The vendor provided an instruction manual and promised shipping within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, posts display black plastic packages with Royal Mail labels, claiming to include new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors usually priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Oversight and Security Measures

A representative for Telegram said it actively monitored harmful material on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“People are administering substances they cannot confirm. Even if the research behind retatrutide is valid, these digital versions may not include what they claim,” said a pharmacy expert, the director of pharmaceutical services at a pharmacy service.

A medical professional of Asda Online Doctor linked the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her staff has already seen patients harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Producer Position

A spokesperson from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any product “falsely representing itself as a Lilly investigational substance not yet approved … may expose patients to possibly serious health risks”.

About the author

Michael Price

Elara is a digital commerce expert who reviews and curates premium online products, helping shoppers find the best value and quality.

Pulse Royal Market

Type to search articles.